Suppr超能文献

天然抗菌酶溶菌酶在胃肠道炎症条件下上调。

The Natural Antimicrobial Enzyme Lysozyme is Up-Regulated in Gastrointestinal Inflammatory Conditions.

机构信息

Gastrointestinal and Liver Pathology Research Laboratory, Department of Pathology, Karolinska Institute and University Hospital, Stockholm 17176, Sweden.

出版信息

Pathogens. 2014 Jan 16;3(1):73-92. doi: 10.3390/pathogens3010073.

Abstract

The cells that line the mucosa of the human gastrointestinal tract (GI, that is, oral cavity, oesophagus, stomach, small intestine, large intestine, and rectum) are constantly challenged by adverse micro-environmental factors, such as different pH, enzymes, and bacterial flora. With exception of the oral cavity, these microenvironments also contain remnant cocktails of secreted enzymes and bacteria from upper organs along the tract. The density of the GI bacteria varies, from 103/mL near the gastric outlet, to 1010/mL at the ileocecal valve, to 1011 to 1012/mL in the colon. The total microbial population (ca. 1014) exceeds the total number of cells in the tract. It is, therefore, remarkable that despite the prima facie inauspicious mixture of harmful secretions and bacteria, the normal GI mucosa retains a healthy state of cell renewal. To counteract the hostile microenvironment, the GI epithelia react by speeding cell exfoliation (the GI mucosa has a turnover time of two to three days), by increasing peristalsis, by eliminating bacteria through secretion of plasma cell-immunoglobulins and by increasing production of natural antibacterial compounds, such as defensin-5 and lysozyme. Only recently, lysozyme was found up-regulated in Barrett's oesophagitis, chronic gastritis, gluten-induced atrophic duodenitis (coeliac disease), collagenous colitis, lymphocytic colitis, and Crohn's colitis. This up-regulation is a response directed to the special types of bacteria recently detected in these diseases. The aim of lysozyme up-regulation is to protect individual mucosal segments to chronic inflammation. The molecular mechanisms connected to the crosstalk between the intraluminal bacterial flora and the production of lysozyme released by the GI mucosae, are discussed. Bacterial resistance continues to exhaust our supply of commercial antibiotics. The potential use of lysozyme to treat infectious diseases is receiving much attention.

摘要

人体胃肠道(GI,即口腔、食管、胃、小肠、大肠和直肠)的黏膜细胞不断受到不利微环境因素的挑战,如不同的 pH 值、酶和细菌菌群。除口腔外,这些微环境还包含沿着肠道的上消化道分泌的酶和细菌的残留混合物。GI 细菌的密度不同,从胃出口附近的 103/mL 到回盲瓣处的 1010/mL,再到结肠的 1011 到 1012/mL。微生物总种群(约 1014)超过了肠道中细胞的总数。因此,尽管表面上分泌的有害物质和细菌混合在一起,但正常的胃肠道黏膜仍能保持健康的细胞更新状态,这是非常了不起的。为了对抗恶劣的微环境,胃肠道上皮通过加速细胞脱落(胃肠道黏膜的更新时间为两到三天)、增加蠕动、通过分泌浆细胞免疫球蛋白消除细菌以及增加天然抗菌化合物(如防御素-5 和溶菌酶)的产生来做出反应。直到最近,溶菌酶才在巴雷特食管炎、慢性胃炎、麸质诱导的萎缩性十二指肠炎(乳糜泻)、胶原性结肠炎、淋巴细胞性结肠炎和克罗恩病中被发现上调。这种上调是针对这些疾病中最近检测到的特殊类型细菌的反应。溶菌酶上调的目的是保护各个黏膜段免受慢性炎症的影响。讨论了与腔内细菌菌群的相互作用以及胃肠道黏膜释放的溶菌酶产生相关的分子机制。细菌耐药性继续耗尽我们商业抗生素的供应。溶菌酶治疗感染性疾病的潜在用途引起了广泛关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a18/4235737/e7bc65616e1a/pathogens-03-00073-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验